August 15, 2026 07:41 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Independence Day: PM Modi’s big youth pitch— AI training, free coaching amid exam row and job concerns | ‘Shakti Ki Saptadhara’: Modi reveals 7 pillars to power India’s next leap in his I-Day speech from Red Fort | West Bengal STF arrests 3 more suspected Pakistani spies in Cooch Behar | Bengal man arrested in Bengaluru over terror links, Afghanistan travel plan | Ajit Doval breaks silence on Operation Sindoor in Discovery’s explosive new docuseries | Rahul Gandhi's 'mock hug' taunt sparks row; Centre stresses 'mutual respect' with Italy | Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe | From guns to glamour: Former women Maoists walk the ramp in Chhattisgarh
Covid Vaccine
Image Credit: Pixabay

Pfizer- BioNTech seek permission for emergency use of Covid-19 vaccine in adolescents in US

| @indiablooms | Apr 10, 2021, at 06:11 am

Washington/IBNS: US drug major Pfizer Inc and its German partner BioNTech SE have sought the permission for emergency use of their vaccine in adolescents aged 12 to 15, according to a Reuters report.

Pfizer Inc and BioNTech stated that they have made a request to the US Food and Drug Administration for the expansion of use of their vaccine which proved to be 90 per cent effective against the novel coronavirus in clinical trials.

In March, the drugmakers said that their vaccine has shown positive results and proven safe among the age group 12 to 15 in a clinical trial.

This could be a big development as drugmakers across the world are still facing the question if the vaccine works and is safe for use in children.

Inoculating children is a major step toward achieving "herd immunity" and controlling the pandemic, according to experts, the report said.

The companies plan to approach other regulatory authorities across the globe for similar permissions.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.